efficacy of glp 1 patches GLP-1 Do GLP-1 Patches Really Work?

Bezin, J

We view the shortage of GLP-1s to be much worse than the official data suggests

Abstract Purpose of Review This review explores the rationale and available evidence behind incretin-based therapies for metabolic dysfunction-associated steatotic disease (MASLD) and metabolic-associated steatohepatitis (MASH), focusing on glucagon-like peptide 1 (GLP-1) and glucagon (GCG) receptor dual agonists (GLP-1/GCG RAs)

The TRIUMPH-4 population (obesity + knee osteoarthritis) may have elevated baseline susceptibility due to existing nerve compression from joint inflammation

They help lower HbA1c levels, which reflect average blood glucose levels over time